US$ 20.20
pfizer glp-1 drug China has approved Pfizer's treatment Xianweiying for long-term weight management in overweight or obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market Pfizer gets green light for
Description
GLP-1s arent for everyone
We comprehensively mapped the benefits and risks of GLP-1 receptor agonists (GLP-1) (Ozempic, Wegovy, Mounjaro, Zepbound)
GLP-1 receptor agonists stimulate the release of insulin, reduce glucagon secretion, and slow down gastric emptying

Weight Support*

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic poly-peptide (GIP, previously known as gastric inhibitory polypeptide) are key incretin
